MNDL Bio

Private

Tel AvivHealthcare & Life Scienceshttps://www.mndl.bio/

Last Round

Seed

Sep 8, 2024

Total Funding Raised

$2.1M

Company Overview

MNDL Bio is a synthetic biology company that provides an AI-powered computational platform to optimize gene expression for recombinant protein production.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

synthetic biologygene expression optimizationprotein productionsynbioprecision fermentationDNA sequence designbiomanufacturingrecombinant proteincomputational biologyAI-driven R&Din silico designbiotech SaaShost optimizationfoodtechbio-design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MNDL Bio Comps

Public and private peers based on sector, stage, and business model.

MNDL Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MNDL Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Sep 8, 2024
Grant	Jul 1, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Steve Grün

Co-founder & CEO

Founding Team

MNDL Bio Investors

Notable investors and investment history

MNDL Bio investors
Investor	Rounds
Israel Innovation Authority	Seed
CPT Capital	Seed
Earth & Beyond Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 8, 2024
$2M round led by Earth & Beyond Ventures.

View all signals

MNDL Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MNDL Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MNDL Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv

Employee Range11

Year Founded2023

Last FundingSep 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.